Form 4 for CAI Caris Life Sciences, Inc.
Accepted 2025-09-12 00:00:00 ET · period of report 2025-09-11 · accession 0001239690-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-12 | 2025-09-11 | CAI | PHILLIPS T DANNY | Dir | M - OptEx | $2.44 | +100.0K | 116.1K | +620% | +$244.0K |
| D | 2025-09-12 | 2025-09-11 | CAI | PHILLIPS T DANNY | Dir | M - OptEx | $0.00 | -100.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-11 | M | A | 100,000 | $2.44 | 116,129 | D | — | — | |
| 2 | Derivative | Stock Option | 2025-09-11 | M | D | 100,000 | $0.00 | 0 | D | $2.44 · — to 2025-09-15 | 100,000 Common Stock | (F1) The stock option is fully vested and exercisable. |